
Articles
-
2 weeks ago |
news.vumc.org | Bill Snyder
Three of the many people who empower the highly impactful and internationally recognized research enterprise at the Vanderbilt University School of Medicine were honored April 4 during the 21st annual Research Staff Awards ceremony at the Kimpton Aertson Hotel in Nashville.
-
2 weeks ago |
news.vumc.org | Bill Snyder
Terrence Allen “TA” Smith, MD, MMHC, a former Vanderbilt faculty member in gastroenterology and a former U.S. Army flight surgeon who served in Iraq, died on April 7 at Vanderbilt University Medical Center from injuries sustained in a bicycle accident. He was 68. “TA was a role model for all of us,” said Richard Peek, MD, the Mina Cobb Wallace Professor of Immunology, professor of Medicine and director of the Division of Gastroenterology, Hepatology and Nutrition.
-
2 weeks ago |
news.vumc.org | Bill Snyder
A research consortium co-led by Vanderbilt University Medical Center and supported in part by the National Institutes of Health has identified three previously unknown genes that cause severe congenital diarrheal disorders in infants. The findings, published April 4 in The New England Journal of Medicine, represent a significant advance toward development of more effective, targeted therapies for congenital diarrhea and enteropathies (CODEs).
-
3 weeks ago |
news.vumc.org | Bill Snyder
Prominent Tennessee banker, businessman and philanthropist James W. “Jim” Ayers, after whom a new, 15-story patient care tower under construction at Vanderbilt University Medical Center is named, died April 1 in Nashville. He was 81. Mr. Ayers and his wife, Janet, have been a major philanthropic force in all of Tennessee.
-
3 weeks ago |
news.vumc.org | Bill Snyder
A multicenter study led by researchers at Vanderbilt University Medical Center has identified multiple new genes associated with benign tumors (fibroids) of the uterus, the leading indication for hysterectomy in the country. Their report, published in the journal Nature Communications, is another step toward development of targeted therapies aimed at reducing the incidence and medical burden of this common condition, which costs the U.S. health care system billions of dollars annually.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →